Structure Therapeutics Inc (GPCR)
41.92
+3.17
(+8.18%)
USD |
NASDAQ |
Sep 20, 16:00
41.85
-0.07
(-0.17%)
After-Hours: 20:00
Structure Therapeutics Net Income (Quarterly): -26.03M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -26.03M |
| March 31, 2024 | -26.04M |
| December 31, 2023 | -24.50M |
| September 30, 2023 | -23.86M |
| June 30, 2023 | -23.28M |
| March 31, 2023 | -17.98M |
| Date | Value |
|---|---|
| December 31, 2022 | -11.88M |
| September 30, 2022 | -12.42M |
| June 30, 2022 | -13.95M |
| March 31, 2022 | -13.08M |
| December 31, 2021 | -11.67M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-26.04M
Minimum
Mar 2024
-11.67M
Maximum
Dec 2021
-18.61M
Average
-17.98M
Median
Mar 2023
Net Income (Quarterly) Benchmarks
| Viking Therapeutics Inc | -22.25M |
| Eli Lilly and Co | 2.967B |
| Amgen Inc | 746.00M |
| Pfizer Inc | 41.00M |
| Novo Nordisk AS | 2.894B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 33.32M |
| EPS Diluted (Quarterly) | -0.54 |
| Enterprise Value | 1.471B |
| Earnings Yield | -5.30% |